Celgene Corp (NYSE:CELGRT)

0.67
Delayed Data
As of 1:24pm ET
 -0.0335 / -4.76%
Today’s Change
0.35
Today|||52-Week Range
1.65
+48.86%
Year-to-Date
Why So Many Biotechs Are Scrambling to Develop a Drug for the Same Rare Disease
Feb 23 / MotleyFool.com - Paid Partner Content
Better Buy: GlaxoSmithKline vs. Bristol-Myers Squibb
Feb 16 / MotleyFool.com - Paid Partner Content
3 Cancer Treatment Stocks to Buy Right Now
Feb 23 / MotleyFool.com - Paid Partner Content
Better Buy: Biogen vs. Bristol-Myers Squibb
Feb 16 / MotleyFool.com - Paid Partner Content
A Big Month Ahead for the FDA and Bristol-Myers Squibb
Feb 22 / MotleyFool.com - Paid Partner Content
3 High-Yielding U.S. Pharmaceutical Companies to Consider
Feb 15 / MotleyFool.com - Paid Partner Content
FDA Approved 1,014 Generic Drugs in 2019
Feb 19 / MotleyFool.com - Paid Partner Content
Could This Cancer Drug Developer’s Stock Make You Rich?
Feb 14 / MotleyFool.com - Paid Partner Content
Why bluebird bio's Q4 Results Really Don't Matter
Feb 19 / MotleyFool.com - Paid Partner Content
White House Claims Other Countries Are "Free-Riding" on U.S. Drug Development
Feb 13 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close0.70
Today’s open0.70
Day’s range0.70 - 0.71
Volume12,716
Average volume (3 months)58,267
Market cap--
Data as of 1:24pm ET, 02/24/2020

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book--

Competitors

No competitors data available.

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)--
Annual profit (last year)--
Net profit margin--

Profile

Sector
--
Industry
--
No executives to display
Corporate headquarters
--, --

Forecasts